However, tumor biopsies from many cases (up to 5 out of 51) showed KRAS mutations that were not found in their corresponding plasma, while the plasma from 4 cases displayed KRAS mutations that were not detected in their corresponding tumoral biopsy sample (Figure 1 and Supplementary Table S1). The gene discussed is KRAS; the disease is neoplasm.